November 13, 2012
HEFFIELD, England - Simcyp (now Certara) has entered into a Cooperative Research and Development Agreement (CRADA) with the US Food and Drug Administration (FDA) to further develop the Simcyp Dog model for the evaluation of drug products intended for use in different canine breeds. This five year project, in conjunction with researchers at the FDA’s [...]
ZEISS Introduces New Family of OCT Products
November 13, 2012
CHICAGO & DUBLIN, Calif. & JENA, Germany -- Medical technology provider Carl Zeiss Meditec announced today the introduction of a new family of ZEISS OCT (Optical Coherence Tomography) products at the 2012 AAO-APAO Joint Meeting in Chicago. The new CIRRUS OCT family is comprised of two new CIRRUS™ HD-OCT products, models 5000 and 500, and [...]
SDIX Reports Third Quarter 2012 Results
November 12, 2012
NEWARK, DE - SDIX (Nasdaq: SDIX), a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology and diagnostic applications, today reported financial results for the quarter ended September 30, 2012. Highlights · Sold Food Safety and GMO Businesses to Romer Laboratories– On September 28, 2012, SDIX announced that it [...]
Oxford Instruments Offers Dune Sciences Silicon Half Grids for In Situ FIB Lift-out
November 12, 2012
Oxford Instruments and Dune Sciences, Inc. have entered into an exclusive worldwide distribution agreement to sell Silicon Half Grids for in situ lift-out. The Dune Sciences’ Silicon Half Grids will be offered for sale on the Omniprobe Products eStore, alongside other consumables and holders for nanofabrication and nanomanipulation. Silicon Half Grids for in situ FIB [...]
Scientists reveal new insights on nano 3D printing
November 12, 2012
A team of physicists funded by FEI Company and the Australian Research Council have unveiled new physics behind the nanofabrication technique known as electron beam induced deposition (EBID), essentially 3D printing at the molecular level. The UTS team has reported new insights into the behaviour of molecules at surfaces to achieve extraordinary improvements in speed [...]
Agilent Technologies Introduces Highly Sensitive Evaporative Light-Scattering Detectors
November 12, 2012
Agilent Technologies Inc. (NYSE: A) today announced two new products-the 1290 Infinity Evaporative Light-Scattering Detector and the 1260 Infinity Evaporative Light-Scattering Detector-that provide up to 9x higher sensitivity, better efficiency and greater reproducibility than any currently available ELSD. Both detectors are ideally suited for the analysis of non- and semi-volatile compounds in pharmaceutical, drug discovery, [...]
California Healthcare Institute Appoints New Board Members
November 12, 2012
La Jolla, Calif. -- CHI-California Healthcare Institute today announced the election of five new executives to its board of directors: Dr. Michael A. Friedman, CEO of City of Hope; Alan J. Malus, executive vice president and president of analytical technologies at Thermo Fisher Scientific; Alberto Mas, worldwide president of BD Biosciences; Heather L. Mason, senior [...]
Hologic Announces Fourth Quarter and Fiscal 2012 Operating Results
November 12, 2012
BEDFORD, Mass., -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced its results for the fourth fiscal quarter and fiscal year ended September 29, 2012. Highlights of the Quarter [...]
2012 Nobel laureate in medicine Shinya Yamanaka reaffirms commitment to CiRA-Cellectis partnership
November 12, 2012
Paris, France, – Cellectis (Alternext: ALCLS), the genomeengineering specialist, was honored to welcome Professor Yamanaka, this year’s Nobel laureate in medicine, for a meeting with the Group's teams at its Paris headquarters. As Europe's stem cell leader, Cellectis anticipated – no later than in 2008 – the extraordinary scientific and industrial potential of new products [...]
Study Shows Sequenom CMM’s RetnaGene LDT Accurately Predicts Risk of Progression to Wet Form of AMD
November 12, 2012
SAN DIEGO, -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced its wholly-owned subsidiary, Sequenom Center for Molecular Medicine (Sequenom CMM), presented results from a study of its RetnaGene AMD laboratory-developed test to predict risk of disease progression during the 2012 Joint Meeting of the [...]

